Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-002520

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Sep 11, 2017
Accepted (ET)
Oct 31, 2017 · 8:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
9.00% Series A Cumulative Preferred StockF1,F4,F2Sep 11, 2017J10,277$50.00A383,985IBy: Lone Star Value Investors, LP
Common StockF1,F7Oct 26, 2017L3$6.25A10,107IBy: Lone Star Value Co-Invest I, LP
Common StockF1,F7Oct 27, 2017P2,500$6.50A12,607IBy: Lone Star Value Co-Invest I, LP
Common StockF1,F7Oct 30, 2017P1,303$6.4994A13,910IBy: Lone Star Value Co-Invest I, LP
Common StockF1,F2holding———2,872,592IBy: Lone Star Value Investors, LP
Common StockF1,F3holding———83,308IBy: Separately Managed Account
Common StockF1holding———27,066D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses